Deceptive Adherence to Anticoagulation in Secondary Stroke Prevention
Table 2
Logistic regression model for factors related to good/full treatment adherence (%).
Odds ratio †
SE
-value
value
95% confidence interval
Age (y)
1.00
0.02
-0.12
0.90
0.95-1.04
Female
1.00
Male
0.79
0.30
-0.64
0.52
0.38-1.64
Recurrent stroke
1.00
First-ever stroke
2.27
0.82
2.26
0.02
1.12-4.61
CHA2DS2-VASc
0.79
0.11
-1.62
0.11
0.60-1.05
HAS-BLED
1.07
0.26
0.29
0.77
0.67-1.72
eGFR
1.00
0.01
0.36
0.72
0.98-1.02
NIHSS at discharge
1.00
0.04
-0.35
0.73
0.92-1.06
Apixaban
1.00
Dabigatran
0.75
0.36
-0.60
0.55
0.29-1.94
Rivaroxaban
0.92
0.36
-0.21
0.84
0.43-1.99
Warfarin
0.63
0.31
-0.93
0.35
0.24-1.65
†Odds ratios are mutually adjusted for all variables presented in the table. MPR: medication possession ratio; SE: standard error; eGFR: estimated glomerular filtration rate; NIHSS: National Institutes of Health Stroke Scale.